MIVU:XETRA:XETRA-Amundi Index Solutions MSCI USA Minimum Volatility Factor UCITS (EUR)

ETF | Others |

Last Closing

USD 96.93

Change

+3.56 (+3.81)%

Market Cap

USD 0.30B

Volume

162.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.89 (+1.76%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.28 (+1.72%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.42 (+1.57%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.45 (+1.61%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.42 (+1.73%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.87 (+1.94%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

+2.20 (+1.54%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.84 (+1.68%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+3.07 (+3.13%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+23.06 (+4.12%)

USD 80.38B

ETFs Containing MIVU:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 23.26% 85% B 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.26% 85% B 84% B
Trailing 12 Months  
Capital Gain 26.21% 73% C 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.21% 73% C 74% C
Trailing 5 Years  
Capital Gain 58.93% 78% C+ 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 58.93% 78% C+ 79% B-
Average Annual (5 Year Horizon)  
Capital Gain 9.97% 69% C- 67% D+
Dividend Return 9.97% 68% D+ 66% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.23% 60% D- 68% D+
Risk Adjusted Return 97.45% 93% A 93% A
Market Capitalization 0.30B 54% F 48% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike